IRM
44
3
VRSK
32
2
OXY
42
2
MS
76
2
PCG
77
3
PFE
45
12
ORCL
37
4
CHD
35
-5
WYNN
48
-2
MOS
32
3
PFG
55
2
SYK
35
4
EMR
67
3
DVA
51
2
PRU
60
-2
FSLR
78
5
HSY
51
8
LUV
70
2
KSS
58
-4
ZBH
44
2
IRM
44
3
VRSK
32
2
OXY
42
2
MS
76
2
PCG
77
3
PFE
45
12
ORCL
37
4
CHD
35
-5
WYNN
48
-2
MOS
32
3
PFG
55
2
SYK
35
4
EMR
67
3
DVA
51
2
PRU
60
-2
FSLR
78
5
HSY
51
8
LUV
70
2
KSS
58
-4
ZBH
44
2
Financhill
Back

Columbia Seligman Premium Technology Growth Fund Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
46

STK
Columbia Seligman Premium Technology Growth Fund

Last Price:
$36.59
Seasonality Move:
0.87%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
46
Columbia Seligman Premium Technology Growth Fund (STK) is a Sell

Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?

  • The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $36.59. The Score for STK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • STK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STK Stock Price Chart

What is Columbia Seligman Premium Technology Growth Fund's stock price today?

  • The Columbia Seligman Premium Technology Growth Fund share price today is $36.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STK is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

STK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.99 Buy
Relative Strength Index (14 RSI): 51.64 Buy
Chaikin Money Flow: -14509 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.62 - 37.36) Buy
Bollinger Bands (100): (32.44 - 37.54) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

STK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.84 Buy
20-day SMA: 36.42 Buy
50-day SMA: 36.84 Sell
200-day SMA: 31.96 Buy
8-day EMA: 22.75 Buy
20-day EMA: 11.8 Buy
50-day EMA: 5.28 Buy
200-day EMA: 1.4 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Columbia Seligman Premium Technology Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):